Spots Global Cancer Trial Database for A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
Official Title: A Phase 2 Randomized Study of BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
Study ID: NCT05005273
Conditions
Study Description
Brief Summary: The purpose of this study is to determine the safety and efficacy of BMS-986207 in combination with nivolumab and ipilimumab as first-line treatment for participants with stage IV non-small cell lung cancer (NSCLC).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0080, Tucson, Arizona, United States
Local Institution - 0051, Fountain Valley, California, United States
Local Institution - 0070, Fort Myers, Florida, United States
Local Institution - 0073, Gainesville, Florida, United States
Local Institution - 0036, Orange City, Florida, United States
Local Institution - 0045, Pensacola, Florida, United States
Local Institution, Port Saint Lucie, Florida, United States
Local Institution - 0068, Saint Petersburg, Florida, United States
Local Institution, Tallahassee, Florida, United States
Local Institution, West Palm Beach, Florida, United States
Local Institution - 0081, Boise, Idaho, United States
Local Institution - 0077, Coeur d'Alene, Idaho, United States
Local Institution - 0074, Edgewood, Kentucky, United States
Local Institution - 0002, Ann Arbor, Michigan, United States
Local Institution - 0049, Brooklyn, New York, United States
Local Institution - 0012, Charleston, South Carolina, United States
Local Institution - 0053, Milwaukee, Wisconsin, United States
Local Institution - 0009, Pergamino, Buenos Aires, Argentina
Local Institution - 0054, Rosario, Santa FE, Argentina
Local Institution - 0062, Buenos Aires, , Argentina
Local Institution - 0021, Buenos Aires, , Argentina
Local Institution - 0011, Buenos Aires, , Argentina
Local Institution - 0048, Buenos Aires, , Argentina
Local Institution - 0057, San Juan, , Argentina
Local Institution - 0063, Orange, New South Wales, Australia
Local Institution - 0056, Wahroonga, New South Wales, Australia
Local Institution - 0052, Warrnambool, Victoria, Australia
Local Institution - 0034, Mechelen, Antwerpen, Belgium
Local Institution - 0040, Charleroi, , Belgium
Local Institution - 0043, Mons, , Belgium
Local Institution - 0019, Sint-Niklaas, , Belgium
Local Institution - 0050, Santiago, Metropolitana, Chile
Local Institution - 0035, Vina del Mar, Valparaiso, Chile
Local Institution - 0015, Vina del Mar, Valparaiso, Chile
Local Institution - 0037, Limoges, , France
Local Institution - 0030, Nantes, , France
Local Institution - 0044, Pessac, , France
Local Institution - 0016, Rouen, , France
Local Institution - 0031, Saint Priest en Jarez, , France
Local Institution - 0013, Suresnes, , France
Local Institution - 0042, Toulon, , France
Local Institution - 0005, Gauting, Bayern, Germany
Local Institution - 0022, Frankfurt, Hessen, Germany
Local Institution - 0017, Gera, , Germany
Local Institution - 0023, Muenchen, , Germany
Local Institution - 0059, Wiesbaden, , Germany
Local Institution - 0064, Haifa, , Israel
Local Institution - 0061, Jerusalem, , Israel
Local Institution - 0078, Jerusalem, , Israel
Local Institution - 0079, Jerusalem, , Israel
Local Institution - 0039, Monza, MB, Italy
Local Institution - 0020, Rozzano, MI, Italy
Local Institution, Milano, , Italy
Local Institution - 0028, Naples, , Italy
Local Institution - 0001, Padova, , Italy
Local Institution - 0024, Bydgoszcz, , Poland
Local Institution - 0003, Lodz, , Poland
Local Institution - 0038, Otwock, , Poland
Local Institution - 0058, Szczecin, , Poland
Local Institution - 0033, Majadahonda, Madrid, Spain
Local Institution - 0041, Alicante, , Spain
Local Institution - 0026, Barcelona, , Spain
Local Institution - 0075, Barcelona, , Spain
Local Institution - 0006, Barcelona, , Spain
Local Institution - 0046, Jaen, , Spain
Local Institution - 0032, Madrid, , Spain
Local Institution - 0076, Istanbul, , Turkey
Local Institution - 0066, Istanbul, , Turkey
Local Institution - 0065, Izmir, , Turkey
Local Institution - 0067, Samsun, , Turkey
Local Institution - 0072, Yuregir, , Turkey
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
